Alpharadin
Navigation Links
Alpharadin in Medical News
... AstraZeneca's zibotentan, Johnson & Johnson's abiraterone and Algeta's alpharadin will fuel market growth. Specifically, sales of Avastin will be driven by its use in combination with Taxotere and sales of alpharadin will be driven by its use in patients who are not suitable for treatment wi...
Algeta Receives IND Approval for Alpharadin(TM) to Commence Clinical Development in the USA
... biodistribution and dosimetry study (BC1-08) with alpharadin in HRPC patients with skeletal metastases will be ...nternational pivotal phase III clinical trial with alpharadin in HRPC patients during the first half of 2008." ...efore mid 2008 based on positive Phase II results. alpharadin is a novel bone-seeking therapeutic based on the a...Alpharadin in Medical Technology
OSLO, Norway, January 14 /PRNewswire-FirstCall/ --
- Results Highlight the Potential of Alpharadin to Treat Bone Metastases
in Major Cancer Indications
Algeta ASA (OSE: ALGETA), the cancer therapeutics company, announces that
with the results of the BC1-04 study reported today i...
...ellent Phase II clinical data for our lead product alpharadin (radium-223) in prostate cancer, which was publish...rostate cancer based on positive Phase II results. alpharadin is a novel bone-seeking therapeutic based on the a...o Stock Exchange in March 2007 (Ticker: ALGETA). alpharadin and Algeta are trademarks of Algeta ASA. Forward...
Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin
OSLO, August 28 /PRNewswire-FirstCall/ -- - Results Further Support the Clinical Profile of This Novel Anti-Cancer Agent Under Development to Improve the Survival of Patients With Hormone Refractory Prostate Cancer (HRPC) Algeta ASA (OSE: ALGETA), the Norwegian cancer therapeutics company,...Algeta to Present Phase II Clinical Study Data for Alpharadin in Prostate Cancer at ASCO
OSLO, Norway, 30 May 2007 - Algeta ASA (OSE: ALGETA), the Norwegian cancer therapeutics company, announces that Professor Øyvind Bruland, of the Norwegian Radium Hospital, Oslo and founder of Algeta, will present a Poster and Discussion entitled, "Radium-223 in the treatment of metastatic h......ellent Phase II clinical data for our lead product alpharadin (radium-223) in prostate cancer, which was publish...rostate cancer based on positive Phase II results. alpharadin is a novel bone-seeking therapeutic based on the a...o Stock Exchange in March 2007 (Ticker: ALGETA). alpharadin and Algeta are trademarks of Algeta ASA. Forward...
Alpharadin in Biological Technology
New Report Just Published: World Prostate Cancer Therapeutics Market Report
...udies II-53 Debiopharm Unveils Results of Phase III Study of Trelstar in Prostate Cancer Treatment II-53 Algeta to Start Clinical Study of alpharadin in HRPC II-53 Ferring Receives FDA Approval for Degarelix in Prostate Cancer II-53 Isis and OncoGenex Reveals Positive results of OGX-011 ...Algeta Appoints Andrew Kay as President and Chief Executive Officer
...ties and Aims to Accelerate Further Development of alpharadin in Advanced Prostate Cancer Algeta ASA (OS...will be of significant value to Algeta in bringing alpharadin to market." Mr. Kay said: "I am delighted ...g Algeta at this crucial point in its development. alpharadin has shown in all the clinical trials completed to ...Other TagsRIBAOther Contentsdaydaydaydaydaydaydaydaydayrosacearotavirusrotavirusrotavirusrotavirusroseolacuffcuffcuffrotatorrotatorrotatorroundwormsroundworms
HVADRB1OligotypingPhenosenseKininogenfingernailsNeutralizationAgglutinationHHV6GestationisHHTTimePCRRIBAChronicwith
(Date:12/16/2009)... of products that help survivors of stroke and other forms ... of an interview with the inventors of their brand new ... and Rehab Medicine, vol. 20, issue 20, page 26, 2009; ... ... (PRWEB) December 16, 2009 -- In the publication, entitled ...
(Date:12/16/2009)... and what would be the perfect gift to give that special ... Beauty Engineer® and Licensed Esthetician Mary Schook introduces exceptional beauty products ... their best! , ... (PRWEB) December 16, 2009 -- ... a person get that special woman who has everything? Why stem ...
(Date:12/15/2009)... successfully developed a new electrophoretic method for detecting ... The technique, using SARCOSYL-PAGE, has specifically enhanced ... performance characteristics of SDS-PAGE for detecting other EPOs. ... grant from the World Anti-Doping Agency (WADA), appear ... and Analysis published by Wiley-Blackwell. , MIRCERA ...
(Date:12/15/2009)... Watchdog Calls For Preserving State Authority, Ban on ... ,, WASHINGTON, Dec. 15 Consumer Watchdog ... for those over 55 and the public option ... the group said that the Senate must still ... bill to prevent ceding the entire health care ...
(Date:12/15/2009)... Palo Alto Networks(TM), the network security ... its PA-4000 Series next-generation firewalls for accurate threat ... visibility and control over applications such as peer-to-peer ... national university with eight facilities on five campuses. ... a number of academic schools and institutions throughout ...
Breaking Medicine News(10 mins):Health News:New Tailwind Device Improves Arm Function in Stroke Survivors with Paralysis 2Health News:New Online Beauty Store Suggests Stem Cells for the Woman Who Has Everything 2Health News:Researchers discover novel method for detecting MIRCERA 2Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 2Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 3Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 4Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 5Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 2Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 3[0] New Tailwind Device Improves Arm Function in Stroke Survivors with Paralysis [0] New Online Beauty Store Suggests Stem Cells for the Woman Who Has Everything[1] Researchers discover novel method for detecting MIRCERA[1] The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System[1] Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University
(Date:12/15/2009)... 2009 Economics, environmental impacts, social dynamics, and ... the overall success of an agroecosystem. Positive or ... forcing individuals and social groups to continuously adapt ... , Experiential learning theory suggests that knowledge ... experiences. Such lessons are especially valuable for environmental ...
(Date:12/15/2009)... American researchers found the fossil remains of a whale, 4.5 ... for the first time, the results of the decay and ... cetacean, possibly a baleen whale from the Mysticeti group. , ... remains of a whale from the Lower Pliocene (five million ... is the first time that the results of the processes ...
(Date:12/15/2009)... Group, a leading real-time and embedded technology engineering services ... three high school teams for the 2010 season of ... ). ,, The PTR Group will provide funding to ... The teams from Atholton HS in Columbia, MD, Rockwall ... Vienna, VA all have direct mentorship from engineers in ...
Breaking Biology News(10 mins):Experiential learning teaches change and adaptation 2Story of 4.5 million-year-old whale unveiled in Huelva 2Story of 4.5 million-year-old whale unveiled in Huelva 3The PTR Group Announces Financial and Technical Support to US FIRST Robotics Competition Teams 2Louisiana 26apos 3Bs TCA Cellular Therapy 26apos 3Bs Findings Reported at World Stem Cell Summit Patients 26apos 3B Legs Saved from Amputation Usin 58110 1Louisiana 26apos 3Bs TCA Cellular Therapy 26apos 3Bs Findings Reported at World Stem Cell Summit Patients 26apos 3B Legs Saved from Amputation Usin 58110 2Louisiana 26apos 3Bs TCA Cellular Therapy 26apos 3Bs Findings Reported at World Stem Cell Summit Patients 26apos 3B Legs Saved from Amputation Usin 58110 3Kayentis the Leading Provider of the Unique 26quot 3BPaper Based e Trial 26quot 3B Solution has been Retained for Six New Clinical Studies in the U 58106 1Kayentis the Leading Provider of the Unique 26quot 3BPaper Based e Trial 26quot 3B Solution has been Retained for Six New Clinical Studies in the U 58106 2New stove dramatically improves lung health in Mexican women 58102 1New stove dramatically improves lung health in Mexican women 58102 2New stove dramatically improves lung health in Mexican women 58102 3| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |